Search Results 361-370 of 18472 for prednisone

1. CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/​Refractory B Cell Malignancies - Mayo Clinic

   ... prednisone or equivalent forms of steroids * History of severe immediate hypersensitivity reaction to CART19, stem cell infusion dimethyl sulfoxide (DMSO) ...

2. Dermatomyositis - Diagnosis & treatment - Mayo Clinic

   Corticosteroids. Medicines such as prednisone can manage dermatomyositis symptoms well. · Corticosteroid-sparing agents. · Medicines for more-serious illness.

3. Diarrhea - Mayo Clinic

   Prednisone withdrawal: Why taper down slowly? Premenstrual dysphoric disorder · Premenstrual syndrome (PMS) · Preterm labor · Primary biliary cholangitis (PBC) ...

4. Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas - Mayo Clinic

   Low doses of steroids (≤ 20 mg of prednisone or equivalent dose of other steroid/day) used for treatment of non-hematologic medical conditions;; Previous ...

5. A Study to Evaluate the Effectiveness and Safety of TD-1473 in Crohn's Disease - Mayo Clinic

   the subject has been on corticosteroid for a minimum of 4 weeks prior to Day 1; AND · the dose is equivalent to or less than prednisone 25 mg/day or budesonide 9 ...

6. A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma - Mayo Clinic

   Ongoing treatment with corticosteroids with a dose >10 mg prednisone or equivalent per day at the time of randomization; or >280 mg cumulative prednisone ...

7. Mononucleosis - Diagnosis & treatment - Mayo Clinic

   Antibody tests. If there's a need for additional confirmation, a monospot test may be done to check your blood for antibodies to the Epstein-Barr virus. This ...

8. Treatment of Recurrent Clostridium Difficile Infection with RBX7455 - Mayo Clinic

   Taking systemic steroids (≥ 20 mg a day or prednisone-equivalent) or is expected to be on steroids after enrollment through 8 weeks after completing the ...

9. Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen - Mayo Clinic

   - Have received radiotherapy <2 weeks prior to randomization. - Have known symptomatic brain metastases requiring steroids >10 mg per day prednisone (or ...

10. Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma - Mayo Clinic

    Participation eligibility · Use of systemic chronic steroid therapy (≥10mg /day of prednisone or equivalent), or any immunosuppressive therapy within 7 days of ...